OTCM
PHCCF
Market cap1.06bUSD
Jul 03, Last price
11.30USD
Name
PHC Holdings Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
Key people
Kaiju Yamaguchi
Managing Executive Officer, Chief Financial Officer · since 2024
Ryuichi Hirashima
Senior Managing Executive Officer, Chief Human Resources Officer, Chief Administrative Officer, Chief Transformation Officer · since 2022
Nobuaki Nakamura
Managing Executive Officer, Manager of Diagnostics and Life Sciences Domain · since 2024
Steven Lynum
Executive Officer, Manager of Diagnostics and Life Sciences Co-Domain
Robert Schumm
Executive Officer, Director of BGM Business · since 2024
Hideaki Takahashi
Executive Officer, Director of Healthcare IT Solution Business · since 2024
Chikara Takauo
Executive Officer, Director of Biomedical Business · since 2024
Kenichi Uchino
Executive Officer, Director of LSIM Business · since 2024
Kyoko Deguchi
President, Chief Executive Officer, Representative Director · since 2024
Koichiro Sato
Vice President, Chief Operating Officer, Chief Strategy Officer, Manager of Diabetes Management Domain, Manager of Healthcare Solutions Domain, Representative Director · since 2024
Yoshiki Yamaguchi
Director · since 2025
Hirofumi Hirano
Independent Director · since 2013
Independent Director · since 2022
Independent Director · since 2021
Misa Yamashita
Independent Director · since 2024
Eiji Yatagawa
Independent Director · since 2022
Headquarters & legal address
有楽町一丁目13番2号
東京都 千代田区 100-8403
JP
東京都 千代田区 100-8403
JP
Address
1-13-2, Yuraku-cho
Chiyoda-ku Tokyo 100-8403
JP
Chiyoda-ku Tokyo 100-8403
JP
Other language
PHC Holdings Corporation
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||